Trial Profile
Pharmacokinetics and pharmacodynamics of prasugrel versus clopidogrel in Chinese volunteers with different CYP2C19 genotypes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2011
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Atherosclerosis; Cardiovascular disorders; Congenital heart defects; Embolism and thrombosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Unstable angina pectoris
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- Sponsors Daiichi Sankyo Inc; Eli Lilly and Company
- 05 Aug 2011 New trial record
- 21 Jun 2011 Results published in the British Journal of Clinical Pharmacology.